A Multicenter, Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer

PURPOSE: To explore the feasibility and efficacy of docetaxel plus prednisone for Chinese population with metastatic castration refractory prostate cancer (mCRPC). PATIENTS AND METHODS: A total of 228 patients recruited from 15 centers were randomized to receive 10 cycles of D3P arm (docetaxel: 75 m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Zhou, Tie, Zeng, Shu-xiong, Ye, Ding-wei, Wei, Qiang, Zhang, Xu, Huang, Yi-ran, Ye, Zhang-qun, Yang, Yong, Zhang, Wei, Tian, Ye, Zhou, Fang-jian, Jie, Jin, Chen, Shi-ping, Sun, Yan, Xie, Li-ping, Yao, Xing, Na, Yan-qun, Sun, Ying-hao
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4307981/
https://ncbi.nlm.nih.gov/pubmed/25625938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0117002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados